Skip to main content
. 2020 Nov 4;1866(2):158849. doi: 10.1016/j.bbalip.2020.158849

Table 2.

Comparison of protein composition, functional receptor and infected mammalian cells of SARS-CoV, MERS-CoV and SARS-CoV-2 [1,[15], [16], [17], [18], [19], [20], [21], [22]].

Protein content Functional receptor Infected mammalian cells
SARS-CoV Replicase polyproteins: pp1a, pp1ab
Structural proteins: spike (S) glycoprotein, membrane (M), envelope (E), nucleocapsid (N)
8 putative proteins
ACE2 airway epithelium, type I and type II pneumocytes, alveolar macrophages
MERS-CoV Structural proteins: spike (S) glycoprotein, membrane (M), envelope (E), nucleocapsid (N) hDPP4 airway epithelium, type I and type II pneumocytes
SARS-CoV-2 Non-structural proteins forming replicase-transcriptase complex: Nsp1-Nsp16
Structural proteins: spike (S) glycoprotein, membrane (M), envelope (E), nucleocapsid (N)
9 accessory factors
ACE2 types I and II pneumocytes, alveolar macrophages

SARS-CoV, Severe Acute Respiratory Syndrome Coronavirus; MERS-CoV, Middle East Respiratory Syndrome Coronavirus; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; ACE2, Angiotensin-Converting Enzyme 2; hDPP4, human dipeptidyl peptidase 4.